127 related articles for article (PubMed ID: 33407483)
21. Recognition of DNA Methylation Molecular Features for Diagnosis and Prognosis in Gastric Cancer.
Liu D; Li L; Wang L; Wang C; Hu X; Jiang Q; Wang X; Xue G; Liu Y; Xue D
Front Genet; 2021; 12():758926. PubMed ID: 34745226
[No Abstract] [Full Text] [Related]
22. A Sparse and Low-Rank Regression Model for Identifying the Relationships Between DNA Methylation and Gene Expression Levels in Gastric Cancer and the Prediction of Prognosis.
Wang Y; Xu L; Ai D
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34199440
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
24. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
25. Screening of Methylation Gene Sites as Prognostic Signature in Lung Adenocarcinoma.
Dong M; Yang Z; Li X; Zhang Z; Yin A
Yonsei Med J; 2020 Dec; 61(12):1013-1023. PubMed ID: 33251775
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of methylated differentially expressed miRNAs and immune infiltrate profile in EBV-associated gastric cancer.
Zhu M; Liang Q; Chen T; Kong Q; Ye G; Yu S; Li X; He Q; Liu H; Hu Y; Yu J; Li G
Clin Epigenetics; 2021 Jan; 13(1):22. PubMed ID: 33514440
[TBL] [Abstract][Full Text] [Related]
27. A methylation-based nomogram for predicting survival in patients with lung adenocarcinoma.
Wang X; Zhou B; Xia Y; Zuo J; Liu Y; Bi X; Luo X; Zhang C
BMC Cancer; 2021 Jul; 21(1):801. PubMed ID: 34247575
[TBL] [Abstract][Full Text] [Related]
28. Clinical potential of DNA methylation in gastric cancer: a meta-analysis.
Sapari NS; Loh M; Vaithilingam A; Soong R
PLoS One; 2012; 7(4):e36275. PubMed ID: 22558417
[TBL] [Abstract][Full Text] [Related]
29. Identification of the subtypes of gastric cancer based on DNA methylation and the prediction of prognosis.
Li T; Chen X; Gu M; Deng A; Qian C
Clin Epigenetics; 2020 Oct; 12(1):161. PubMed ID: 33115518
[TBL] [Abstract][Full Text] [Related]
30. Signature based on molecular subtypes of deoxyribonucleic acid methylation predicts overall survival in gastric cancer.
Bian J; Long JY; Yang X; Yang XB; Xu YY; Lu X; Sang XT; Zhao HT
World J Gastroenterol; 2020 Nov; 26(41):6414-6430. PubMed ID: 33244202
[TBL] [Abstract][Full Text] [Related]
31. An integrated methylation and gene expression microarray analysis reveals significant prognostic biomarkers in oral squamous cell carcinoma.
Zhao C; Zou H; Zhang J; Wang J; Liu H
Oncol Rep; 2018 Nov; 40(5):2637-2647. PubMed ID: 30226546
[TBL] [Abstract][Full Text] [Related]
32. An integrative approach identified genes associated with drug response in gastric cancer.
Zhou J; Yong WP; Yap CS; Vijayaraghavan A; Sinha RA; Singh BK; Xiu S; Manesh S; Ngo A; Lim A; Ang C; Xie C; Wong FY; Lin SJ; Wan WK; Tan IB; Flotow H; Tan P; Lim KH; Yen PM; Goh LK
Carcinogenesis; 2015 Apr; 36(4):441-51. PubMed ID: 25742747
[TBL] [Abstract][Full Text] [Related]
33. A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer.
Li C; Zheng Y; Pu K; Zhao D; Wang Y; Guan Q; Zhou Y
Cancer Cell Int; 2020; 20():88. PubMed ID: 32206039
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive Analysis of Alternative Splicing Signature in Gastric Cancer Prognosis Based on The Cancer Genome Atlas (TCGA) and SpliceSeq Databases.
Cheng X; Li X; Gu Y; Zhou L; Tang J; Dai X; Jiang H; Huang Y; Zhang Y; Xu T; Liu Z; Zhao Q
Med Sci Monit; 2020 Nov; 26():e925772. PubMed ID: 33219199
[TBL] [Abstract][Full Text] [Related]
35. Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.
Cai WY; Dong ZN; Fu XT; Lin LY; Wang L; Ye GD; Luo QC; Chen YC
Theranostics; 2020; 10(19):8633-8647. PubMed ID: 32754268
[No Abstract] [Full Text] [Related]
36. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
37. eIF4EBP3 was downregulated by methylation and acted as a tumor suppressor by targeting eIF4E/β-catenin in gastric cancer.
Zhai S; Lin S; Lin Z; Xu J; Ji T; Chen K; Wu K; Liu H; Ying H; Fei W; Wang J; Fu G; Wang Y; Hu X; Cai X
Gastric Cancer; 2020 May; 23(3):483-496. PubMed ID: 31853750
[TBL] [Abstract][Full Text] [Related]
38. Hypomethylated gene NRP1 is co-expressed with PDGFRB and associated with poor overall survival in gastric cancer patients.
Wang G; Shi B; Fu Y; Zhao S; Qu K; Guo Q; Li K; She J
Biomed Pharmacother; 2019 Mar; 111():1334-1341. PubMed ID: 30841447
[TBL] [Abstract][Full Text] [Related]
39. A 21‑gene Support Vector Machine classifier and a 10‑gene risk score system constructed for patients with gastric cancer.
Jiang H; Gu J; Du J; Qi X; Qian C; Fei B
Mol Med Rep; 2020 Jan; 21(1):347-359. PubMed ID: 31939629
[TBL] [Abstract][Full Text] [Related]
40. An 8-gene DNA methylation signature predicts the recurrence risk of cervical cancer.
Ma JH; Huang Y; Liu LY; Feng Z
J Int Med Res; 2021 May; 49(5):3000605211018443. PubMed ID: 34034542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]